Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefaclor versus amoxicillin-clavulanate tolerability in children with upper respiratory bacterial infections
2005-004363-34Phase 4Completed
- Sponsor
- Valeas
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of cefaclor and amoxicillin + clavulanate in pharyngitis, tonsillopharyngitis, rhinosinusitis and 1 more (2 arms), sponsored by Valeas. Primary endpoint: Primary tolerability endpoint. Started Dec 2007; status: completed.
02
Drugs
cefacloramoxicillin + clavulanate
03
Conditions
pharyngitistonsillopharyngitisrhinosinusitisupper respiratory infection (URI)
Beyond the preview
Go deeper on 2005-004363-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004363-34.